Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-

MRNA: Moderna, Inc.
2021-11-15 08:35:00
Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Beyond Technical Analysis

면책사항